331 results on '"Topaloglu, O."'
Search Results
2. RWD16 Role of Real-World Evidence for Treatments Granted Access Under Cancer Drugs Fund: Lessons and Insights From Review of NICE Technology Assessment Reports (2019-2022)
3. EE68 Burden of Hospitalization, Costs and Co-Morbidities in Patients With Chronic Lymphocytic Leukemia: Analysis of Real-World Evidence Using National In-Patient Hospital Database
4. P47 Understanding Evidence Requirements for Diagnostic Devices for Reimbursement and Market Access: Insights and Lessons From Review of NICE Diagnostics Assessment Reports (2011-2022)
5. RWD79 Burden of Hospitalization, Costs and Comorbidities in Medicaid Patients With Veno-Occlusive Disease (VOD): Analysis of National In-Patient Hospital Database
6. HTA216 Assessment of Key Drivers of Economic Evaluations for Digital Health and Medical Technologies: Insights and Lessons From Review of NICE Medical Technology Assessment Reports (2010-2022)
7. HTA83 Role of Quality of Life in Health Technology Assessment Agency Final Recommendations: Insights and Lessons From Review of NICE Technology Assessment Reports (2019-2022)
8. CO48 Systematic Literature Review and Meta-Analysis of Endoscopic Improvement for Treatment of Moderate-Severe Ulcerative Colitis
9. EE613 Burden of Hospitalization, Costs and Co-Morbidities in Medicare Patients With Chronic Graft Versus Host Disease: Analysis of National In-Patient Hospital Database
10. EE605 Feasibility Assessment of Using MiToS Staging System for Conducting Health Economic Analysis in Amyotrophic Lateral Sclerosis (ALS)
11. CO11 Comparison of Relapse Rates in Ulcerative Colitis Patients With Mayo Endoscopic Score of 0 or 1: Systematic Literature Review and Meta-Analysis
12. CO119 Systematic Review and Meta-Analysis of Mucosal Healing Outcomes With Biologics in Treatment of Ulcerative Colitis and Crohn's Disease
13. HTA36 Value of Real-World Evidence for Treatments for Ultra Orphan or Rare Diseases: Lessons and Insights From Review of NICE Highly Specialized Technology Assessment Reports (2016-2022)
14. HPR246 Oncology Drug Prices in the United States and Spain: Implications for Pricing Strategy and Drug Access
15. EE321 Hospitalization Burden of Congenital Adrenal Hyperplasia in New England: A Six-Cohort Analysis of National In-Patient Data (2016-2020)
16. MSR174 Leveraging Chat-GPT for Conducting Systematic Literature Reviews
17. CO36 Placebo Effect for Clinical Remission in Induction and Maintenance Treatment in Crohn's Disease: A Systematic Literature Review and Meta-Analysis
18. HTA227 Evaluating the Importance of Patient Input in NICE Highly Specialized Technology (HST) Assessments: Insights From Review Reports
19. HTA230 Indirect Treatment Comparisons in NICE Highly Specialized Technology Assessments
20. HTA229 Feasibility Assessment for Using Chat-GPT for Developing Global Value Dossier
21. HTA228 Missed Opportunities in Cost-Effectiveness Analyses for Rare Disease Treatments: A Systematic Review of Uncaptured Benefits Reported in NICE Highly Specialized Technology Assessments
22. MSR173 Using Chat-GPT for Completing Quality Assessment Questionnaires in Systematic Literature Reviews
23. HTA226 Lack of Face Validity in Health Technology Assessments: Systematic Review of NICE Assessments and Lessons Learned
24. EE322 Understanding Real-World Trends in High Costs, Comorbidities, and Mortality: A Percentile-Based Cohort Comparison in Severe Obesity
25. EE325 Hospitalizations From Veno-Occlusive Disease in the US Pacific Region: A Six-Cohort Analysis of National In-Patient Data (2016-2020)
26. EE324 Hospitalization Burden of Continuous Spikes and Waves During Slow-Wave Sleep (CSWS) in the Middle Atlantic: A Six-Cohort Analysis of Pooled National In-Patient Data (2016-2020)
27. PB2335: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN MEDICAID PATIENTS WITH SICKLE CELL DISEASE (SCD): ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
28. PB2333: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN MEDICARE PATIENTS WITH CHRONIC GRAFT VERSUS HOST DISEASE: ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
29. PB2336: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN MEDICAID PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
30. PB2334: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
31. PB2337: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN MEDICAID PATIENTS WITH VENO-OCCLUSIVE DISEASE (VOD): ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
32. Obstructive sleep apnea syndrome and its association with vitamin D deficiency
33. Assessment of left ventricular functions by tissue Doppler echocardiography in patients with Cushing’s disease
34. Is there a Relationship between Serum IGF-1 and Thyroid Nodule, Thyroid or Ovarian Volume in Polycystic Ovarian Syndrome?
35. Effects of percutaneous laser ablation treatment in benign solitary thyroid nodules on nodule volume, thyroglobulin and anti-thyroglobulin levels, and cytopathology of nodule in 1 yr follow-up
36. EE552 Importance of Half Cycle Correction for Cost-Effectiveness Analysis: Case Study of Sacubitril/Valsartan Vs in Enalapril Heart Failure with Reduced Ejection Fraction
37. RWD170 Understanding Burden of Veno-Occlusive Disease (VOD): Comparison of Hospital Stays with Vod Principal Versus Secondary Diagnosis
38. RWD172 Incidence and Burden of Bronchiectasis in Patients with Primary Immunodeficiency (PI) Diseases
39. RWD113 Understanding Burden and Drivers of Long Hospital Length of Stay in Patients with Heart Failure with Reduced Ejection Fraction (HFREF)
40. RWD98 Understanding the Role of Real-World Evidence for Reimbursement and Market Access of Ultra Orphan Drugs: Insights and Lessons from Case Studies of NICE Highly Specialized Technology (HST) Assessment Reports
41. RWD49 Burden of Hospitalizations in Amyotrophic Lateral Sclerosis (ALS): Comparison of Medicare and Private Payer Populations
42. RWD24 Veno-Occlusive Disease (VOD) Incidence and Treatment Trends Insights from Latest Systematic Review of Case Reports (2018-2023)
43. HTA44 Economic Modeling Insights for Ultra Orphan Drugs Based on Review of NICE Highly Specialized Technology (HST) Assessment Reports
44. HTA9 Evidence Generation Strategy and Insights for Rare Diseases: Case Studies of Mistakes Identified By NICE in Highly Specialized Technology (HST) Assessments
45. HPR64 Implications of Inflation Reduction Act (IRA) on Budget Impact and Cost-Effectiveness Modeling
46. EE200 Simple Approach for Developing Parametric Survival Based Cost-Effectiveness Analysis (CEA): Case Study of Heart Failure with Reduced Ejection Fraction (HFREF)
47. EE193 Burden of Severe Infections in Primary Immunodeficiency (PI) Diseases
48. EE87 Insights and Lessons from Systematic Literature Review of Budget Impact Model Methodologies for United States Payers
49. Is There a Relationship between Serum IGF-1 and Thyroid Nodule, Thyroid or Ovarian Volume in Polycystic Ovarian Syndrome?
50. Quality of Life Outcomes in Treatments for Symptomatic Uterine Fibroids: A Systematic Literature Review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.